<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000za 4500</marc:leader>
    <marc:controlfield tag="001">9.823970</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20221107144021</marc:controlfield>
    <marc:controlfield tag="007">cr |||||||||||</marc:controlfield>
    <marc:controlfield tag="008">160912s2003    onc    |o    f|0| 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">H14-217/2003E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="0" ind2="0">
      <marc:subfield code="a">Report on the mid-term review of the Transfusion-Transmitted Injuries Surveillance System of Health Canada </marc:subfield>
      <marc:subfield code="h">[electronic resource] : </marc:subfield>
      <marc:subfield code="b">final report / </marc:subfield>
      <marc:subfield code="c">[prepared by Consulting and Audit Canada]. </marc:subfield>
    </marc:datafield>
    <marc:datafield tag="246" ind1="1" ind2="7">
      <marc:subfield code="a">Mid-term evaluation of TTISS - Health Canada : </marc:subfield>
      <marc:subfield code="b">final report</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="260" ind1=" " ind2=" ">
      <marc:subfield code="a">[Ottawa] : </marc:subfield>
      <marc:subfield code="b">Health Canada, </marc:subfield>
      <marc:subfield code="c">2003.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">4, v, 45 p.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Title from cover.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"October 2, 2003."</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Summary only, issued in French under title: Rapport de l’examen à mi-parcours du Système de surveillance des incidents transfusionnels de Santé Canada : sommaire.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"Presented to Health Canada, Departmental Audit and Evaluation Committee."</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="504" ind1=" " ind2=" ">
      <marc:subfield code="a">Includes bibliographical references.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1="0" ind2=" ">
      <marc:subfield code="a">On June 2, 1998, the Government of Canada authorized $125 million in additional funding over five years to Health Canada (HC) to establish the Blood Safety Program (BSP). In 1999, Health Canada introduced the Transfusion-Transmitted Injuries Surveillance System (TTISS) component of the BSP to pilot the surveillance of adverse events, including infectious diseases and allergic and immune-mediated events, associated with the transfusion of blood products. Recently, Health Canada requested Consulting and Audit Canada (CAC) to conduct a mid-term evaluation of the progress of the TTISS. This report contains the results of that evaluation. The evaluation was carried out between October 2002 and January 2003. The evaluation focused on the progress of the TTISS towards implementation of a surveillance system for adverse reaction to blood transfusions in hospitals across Canada and on the progress of related research projects funded under the program.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Blood supply</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Safety measures</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Program assessment</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada.</marc:subfield>
      <marc:subfield code="b">Health Canada.</marc:subfield>
      <marc:subfield code="b">Departmental Audit and Evaluation Committee.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada.</marc:subfield>
      <marc:subfield code="b">Consulting and Audit Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Rapport de l'examen à mi-parcours du Système de surveillance des incidents transfusionnels de Santé Canada </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.823971</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">372 KB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2016/sc-hc/H14-217-2003-eng.pdf</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
